Target Name: OR52E1
NCBI ID: G79296
Review Report on OR52E1 Target / Biomarker Content of Review Report on OR52E1 Target / Biomarker
OR52E1
Other Name(s): Olfactory receptor, family 52, subfamily E, member 1 (gene/pseudogene) | OR52E1P | seven transmembrane helix receptor | olfactory receptor, family 52, subfamily E, member 1 pseudogene | olfactory receptor family 52 subfamily E member 1 (gene/pseudogene)

OR52E1: A GPCR Involved in The Sense of Smell

Olfactory receptor, family 52, subfamily E, member 1 (OR52E1) is a protein that plays a crucial role in human sensory function. OR52E1 is a G protein-coupled receptor (GPCR), which means it is a transmembrane protein that is connected to the intracellular signaling pathway. OR52E1 is expressed in the sensory neurons of the central nervous system and is involved in the sense of smell.

OR52E1 is a member of the Olfactory Receptor protein family, which consists of over 300 different genes that are involved in the sense of smell. The Olfactory Receptor protein family is one of the most well-studied GPCR families in the human genome, and many of these genes have been implicated in various neurological and psychiatric disorders.

OR52E1 is a pseudogene, which means that it is a genetic copy of a gene that does not code for a functional protein. OR52E1 is one of the most well-studied pseudogenes in the human genome, and its function and regulation are still being explored.

OR52E1 is expressed in the sensory neurons of the central nervous system, and its function in the sense of smell is still being fully understood. Many studies have shown that OR52E1 is involved in the detection and recognition of scents, and that it plays a role in the sense of smell. OR52E1 is also involved in the regulation of pain and anxiety, and is thought to be involved in the development of certain psychiatric disorders.

Due to its involvement in the sense of smell and its potential role in various neurological and psychiatric disorders, OR52E1 has received a lot of attention as a drug target. Many researchers are actively searching for small molecules that can modulate the activity of OR52E1, with the goal of developing new treatments for various psychiatric and neurological disorders.

One approach that is being explored is the use of small molecules to modulate the activity of OR52E1. Many researchers have shown that small molecules such as peptides and small nucleotides can interact with OR52E1 and modulate its activity. These small molecules can be used to either activate or inhibit the activity of OR52E1, and can be used to treat a variety of psychiatric and neurological disorders.

Another approach that is being explored is the use of gene editing techniques to modify the OR52E1 gene and create new variants that may be involved in the development of psychiatric and neurological disorders. This approach is still in its early stages, but it holds great promise as a tool for the development of new treatments for psychiatric and neurological disorders.

In conclusion, Olfactory receptor, family 52, subfamily E, member 1 (OR52E1) is a protein that plays a crucial role in human sensory function. OR52E1 is a GPCR and a member of the Olfactory Receptor protein family. Its function in the sense of smell and its potential role in various neurological and psychiatric disorders have made it an attractive target for drug development. Many researchers are actively searching for small molecules and gene editing techniques that can modulate the activity of OR52E1. Further studies are needed to fully understand the function and regulation of OR52E1 and its potential as a drug target.

Protein Name: Olfactory Receptor Family 52 Subfamily E Member 1 (gene/pseudogene)

Functions: Odorant receptor

The "OR52E1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR52E1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1